cathepsin B Activators

Cathepsin B activators constitute a diverse array of compounds with distinct mechanisms of action, shedding light on the intricate regulation of this protease. Cathepsin B, a lysosomal cysteine protease, plays a pivotal role in cellular processes, and the modulation of its activity by various activators reflects the complexity of its regulatory network. E-64 and CA-074 exemplify direct modulation of cathepsin B, but through different mechanisms. E-64 disrupts the proteolytic cascade by inhibiting cysteine proteases, indirectly leading to enhanced cathepsin B activity. Conversely, CA-074 directly inhibits cathepsin B's degradation, resulting in its accumulation within lysosomes and subsequent activation. These mechanisms highlight the intricate control of cathepsin B activation within the lysosomal environment. Peptide-based activators, such as GB111-NH2, mimic endogenous substrates, inducing conformational changes in cathepsin B and promoting its catalytic activity. This approach emphasizes the significance of substrate recognition in regulating cathepsin B function. Small molecules like NSC 405020 and SID 26681509 take an indirect route by influencing signaling pathways. NSC 405020 modulates mTOR signaling, increasing autophagy and, consequently, cathepsin B expression. SID 26681509, in contrast, enhances cathepsin B activity by modulating the NF-κB pathway, leading to transcriptional upregulation. Ammonium chloride and Concanamycin A provide a different perspective by indirectly activating cathepsin B through alterations in lysosomal pH. These compounds stabilize cathepsin B, preventing its auto-degradation and ensuring sustained enzyme activity. Dipeptidyl nitrile and LY364947 contribute to the diversity of cathepsin B modulators by reversibly inhibiting cathepsin B and suppressing the TGF-β signaling pathway, respectively.